SynthesisSystematic reviews2026
Meta-analysis of the effects of ginger supplementation on glycemic control, blood pressure and lipid profile in patients with type 2 diabetes.
Synthesis in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGinger has shown promising effects on metabolism in preclinical and clinical studies. This updated and comprehensive meta-analysis aimed to investigate the effects of ginger on the cardiometabolic profile of patients with type 2 diabetes.
methodsScopus, PubMed, the Cochrane Library, and Web of Science were searched from the inception to July 2, 2025, to find randomized controlled trials that compared the effects of ginger with placebo on glycemic indexes, blood pressure, and lipid profile among those with type 2 diabetes. A random-effects model (DerSimonian-Laird) was employed to pool data because of high heterogeneity.
resultsIn total, 13 articles were included in this meta-analysis. Ginger supplementation was associated with a statistically significant reduction in fasting blood sugar (FBS) (MD -16.27 mg/dl, 95% CI (-25.75, -6.80), I
conclusionThis meta-analysis indicated that ginger may probably improve the metabolic indices of patients with type 2 diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.